Torrent Pharmaceutical Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Dr. Divya Colin15 April 2024 6:00 PM ISTNew Delhi: Reviewing the justification presented by the drug major Torrent Pharmaceutical, the Subject Expert Committee (SEC) functional under the...
Drug Safety Alert: IPC Flags ADR Linked To Cefuroxime, Nimesulide, Dutasteride plus Tamsulosin and some Beta-blockers Susmita Roy14 April 2024 6:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert, has revealed adverse drug reactions linked with...
Submit analysis of clinical data of Asian, Indian Population: CDSCO Panel Tells AstraZeneca on Durvalumab Dr. Divya Colin13 April 2024 6:00 PM ISTNew Delhi: In response to the drug major AstraZeneca's proposal for the approval of additional indication of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL...
Submit global regulatory status of Atezolizumab for IV, SC route: CDSCO Panel Tells Roche Products India Dr. Divya Colin12 April 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Roche Products India for granting permission to import and market Atezolizumab...
CDSCO Panel grants AstraZeneca's proposal for withdrawing specific Indications of Olaparib Tablets Dr. Divya Colin11 April 2024 6:00 PM ISTNew Delhi: Reviewing the Clinical evidence presented by drug major AstraZeneca, the Subject Expert Committee (SEC) functional under the Central Drug...
Conduct Phase-III clinical trial: CDSCO Panel tells Abbott on Ademetionine for Injection 400mg Dr. Divya Colin10 April 2024 6:00 PM ISTNew Delhi: Responding to the proposal of import and marketing of Ademetionine for injection 400mg, the Subject Expert Committee (SEC) functional under...
Eli Lilly Gets CDSCO Panel Nod To Import, Market Anti-cancer Drug Selpercatinib Dr. Divya Colin9 April 2024 6:00 PM ISTNew Delhi: Advising to conduct the Phase IV clinical trial, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sun Pharmaceutical Industries Gets CDSCO Panel Nod to Study FDC of Relugolix, Estradiol, Norethindrone Acetate Dr. Divya Colin8 April 2024 6:00 PM ISTNew Delhi: Rejecting for clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Eli Lilly Gets CDSCO Panel Nod To Market Mirikizumab for ulcerative colitis in adults Dr. Divya Colin7 April 2024 6:00 PM ISTNew Delhi: Pharmaceutical major Eli Lilly has got marketing authorization from the Subject Expert Committee (SEC) functional under the Central Drug...
Sun Pharma Industries Gets CDSCO Panel Nod To Manufacture Market Elagolix Tablets 150 mg,200 mg Dr. Divya Colin6 April 2024 6:00 PM ISTNew Delhi: With the condition to be sold by retail under the prescription of a Gynaecologist only, pharmaceutical major Sun Pharma Industries has got...
54 medicines will see only 1 paisa hike: Health Ministry after media reports on drug price hike Ruchika Sharma5 April 2024 2:23 PM ISTNew Delhi: Responding to several media reports about the price rise of essential medicines from April 1, 2024, the Ministry of Health and Family...
Glyceryl Trinitrate, Isosorbide Dinitrate Removed from Schedule P1: MoHFW Dr. Divya Colin4 April 2024 6:00 PM ISTNew Delhi: The Ministry of Health and Family Welfare has amended the Drugs Rules, 1945 by removing Glyceryl Trinitrate and Isosorbide Dinitrate from...
